DexCom Inc. (DXCM) 12-Month Stock Forecast & Price Target Cone
DexCom Inc. (DXCM) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (60% profit margin, 22% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Drag to Test Your DXCM Position Size: $10,000
Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)
Street Historical Accuracy: 64/100| Wall Street Firm | Stance | 12M Target | 1Y Accuracy | Track Grade |
|---|---|---|---|---|
| Morgan StanleyInstitutional Equity Desk | OUTPERFORM | $89 | 74% | A |
| Goldman SachsSector Coverage Lead | BUY | $95 | 69% | B |
| JP MorganUS Large-Cap Research | HOLD | $75 | 58% | C |
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live DXCM Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
DXCM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +15.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DXCM today. View full Setup Ledger →
DXCM Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhat is DXCM's 12-month stock price target?
DexCom Inc. (DXCM) carries a 12-month consensus base price target of $85.33 (+6.8% from $79.93), with a bull-case target of $100.69 and a bear-case floor of $65.54.
Is DXCM stock a Buy, Hold, or Sell right now?
Roarable's 5-Pillar RQD Quant Engine rates DXCM B (Buy — BUY) with an RQD Confidence score of 73/100.